We are live on ! Find out more
GCP

GSA Capital Partners Portfolio holdings

AUM $1.59B
1-Year Est. Return 39.81%
This Fund
S&P 500
This Quarter Est. Return
-5.09%
1 Year Est. Return
+39.81%
3 Year Est. Return
+94.75%
5 Year Est. Return
+73.44%
10 Year Est. Return
+404.29%
AUM
$745M
AUM Growth
-$51.2M
Cap. Flow
-$4.97M
Cap. Flow %
-0.67%
Top 10 Hldgs %
3.53%
Holding
1,995
New
631
Increased
376
Reduced
341
Closed
636

Top Buys

Rank Stock Value
1
KOD icon
Kodiak Sciences
KOD
+$3.17M
2
CSTM icon
Constellium
CSTM
+$2.67M
3
KTB icon
Kontoor Brands
KTB
+$2.5M
4
SMTC icon
Semtech
SMTC
+$2.34M
5
CXT icon
Crane NXT
CXT
+$2.34M

Sector Composition

Rank Sector Weight
1 Healthcare 16.38%
2 Industrials 16.37%
3 Technology 14.13%
4 Consumer Discretionary 10.96%
5 Financials 10.32%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DADA
551
DELISTED
Dada Nexus
DADA
$486K 0.07%
53,233
+4,839
+10% +$47.2K
CBD
552
DELISTED
Companhia Brasileira de Distribuicao
CBD
$484K 0.07%
+96,026
New +$408K
NRG icon
553
NRG Energy
NRG
$24.8B
$483K 0.06%
+12,598
New +$491K
VSTO
554
DELISTED
Vista Outdoor Inc.
VSTO
$483K 0.06%
13,524
-9,290
-41% -$359K
LXRX icon
555
Lexicon Pharmaceuticals
LXRX
$1.1B
$482K 0.06%
230,503
+198,941
+630% +$551K
UE icon
556
Urban Edge Properties
UE
$2.73B
$482K 0.06%
+25,218
New +$467K
BOOT icon
557
Boot Barn
BOOT
$4.95B
$478K 0.06%
+5,046
New +$479K
CYRX icon
558
CryoPort
CYRX
$762M
$478K 0.06%
13,706
+9,534
+229% +$360K
PLRX icon
559
Pliant Therapeutics
PLRX
$65M
$478K 0.06%
68,236
+9,643
+16% +$98.4K
UCB
560
United Community Banks
UCB
$4.28B
$478K 0.06%
+13,737
New +$506K
XIFR
561
XPLR Infrastructure LP
XIFR
$1.08B
$478K 0.06%
5,729
-9,127
-61% -$702K
ROIC
562
DELISTED
Retail Opportunity Investments Corp.
ROIC
$477K 0.06%
+24,615
New +$460K
BAP icon
563
Credicorp
BAP
$30.7B
$476K 0.06%
+2,771
New +$418K
FBP icon
564
First Bancorp
FBP
$4.38B
$476K 0.06%
+36,257
New +$516K
PCOR icon
565
Procore
PCOR
$8.67B
$476K 0.06%
+8,216
New +$522K
ETRN
566
DELISTED
Equitrans Midstream Corporation Common Stock
ETRN
$476K 0.06%
+56,365
New +$464K
FLNC icon
567
Fluence Energy
FLNC
$2.44B
$475K 0.06%
+36,219
New +$607K
QCOM icon
568
Qualcomm
QCOM
$176B
$473K 0.06%
3,098
+1,534
+98% +$257K
TBPH icon
569
Theravance Biopharma
TBPH
$877M
$473K 0.06%
+49,456
New +$485K
CTXS
570
DELISTED
Citrix Systems Inc
CTXS
$473K 0.06%
+4,686
New +$473K
ALLT icon
571
Allot
ALLT
$383M
$472K 0.06%
58,314
+6,069
+12% +$55.3K
KR icon
572
Kroger
KR
$34.8B
$472K 0.06%
8,221
-7,547
-48% -$375K
QVCGA
573
DELISTED
QVC Group Inc Series A
QVCGA
$472K 0.06%
1,983
-60
-3% -$19.1K
AOS icon
574
A.O. Smith
AOS
$8.7B
$471K 0.06%
+7,372
New +$536K
CUE icon
575
Cue Biopharma
CUE
$114M
$471K 0.06%
3,219
-108
-3% -$22.9K

Similar funds

GSA Capital Partners's Q1 2022 Portfolio in Review

As of Q1 2022, GSA Capital Partners held 1,995 positions worth $745M, down 6.4% from $796M the previous quarter. Its ten largest holdings account for 3.5% of the portfolio.

GSA Capital Partners's Q1 2022 filing shows 631 new, 376 increased, 341 reduced and 636 closed positions. Its largest new stake was Kodiak Sciences: 81,285 shares worth $628K. The largest sale was State Street Consumer Staples Select Sector SPDR ETF, an estimated $2.96M.

By sector, the portfolio is most concentrated in Healthcare at 16% of assets, down from 16% a quarter earlier, followed by Industrials and Technology.

  • GSA Capital Partners's largest Q1 2022 buy was Kodiak Sciences: 81,285 shares worth $628K.
  • GSA Capital Partners added most to UMB Financial in Q1 2022, an estimated $1.88M increase.
  • GSA Capital Partners's biggest Q1 2022 reduction was Cleveland-Cliffs, cutting an estimated $2.09M.
  • GSA Capital Partners fully exited State Street Consumer Staples Select Sector SPDR ETF in Q1 2022, selling an estimated $2.96M.
  • GSA Capital Partners's ten largest holdings make up 3.5% of its $745M portfolio in Q1 2022.
  • GSA Capital Partners opened 631 new positions and closed 636 in Q1 2022.
  • GSA Capital Partners's portfolio value fell 6.4% quarter-over-quarter to $745M.

Based on GSA Capital Partners's 13F filing for Q1 2022, filed 11 May 2022.